Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 3/20 | 0.37 |
| ▸ | PTGER2 | P43116 | 8/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.34 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.34 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.34 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.34 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.34 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4129256 | 0.91 | NAMPT (0.39) | NAMPTPTGER2ABCC9ABCC8KCNJ11 | |
| SCHEMBL4126083 | 0.90 | GPBAR1 (0.36) | NAMPTPTGER2GPBAR1LMNACA12 | |
| SCHEMBL3653190 | 0.88 | ABCC9 (0.33) | NAMPTPTGER2FEN1ABCC9ABCC8 | |
| SCHEMBL3653193 | 0.87 | PTGER2 (0.35) | NAMPTPTGER2FEN1ABCC9ABCC8 | |
| SCHEMBL3782033 | 0.86 | NAMPT (0.37) | NAMPTPTGER2FEN1TAS2R14GPBAR1 | |
| SCHEMBL3652974 | 0.82 | CYP2A6 (0.39) | NAMPTFEN1ABCC9ABCC8KCNJ11 | |
| SCHEMBL4126590 | 0.82 | NAMPT (0.35) | NAMPTFEN1ABCC9ABCC8KCNJ11 | |
| Fumaric Acid SCHEMBL3651792 | 0.82 | TBXAS1 (0.36) | NAMPTABCC9ABCC8KCNJ11KCNJ8 | |
| Fumaric Acid SCHEMBL3651794 | 0.82 | TBXAS1 (0.36) | NAMPTABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL4118018 | 0.81 | NAMPT (0.41) | NAMPTPTGER2ABCC9ABCC8KCNJ11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2190822-B1 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2014-12-31 | — | — | EP | disclosed |
| US-20090156642-A1 | 5-Membered heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156642-A1 | 5-Membered heterocyclic compound | CEL, PGA5, COG5 | NAMPT 2129/4885PTGER2 1424/4885FEN1 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.